Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
15.57
+0.95 (6.50%)
At close: Sep 5, 2025, 4:00 PM
15.56
-0.01 (-0.06%)
After-hours: Sep 5, 2025, 6:43 PM EDT
Edgewise Therapeutics Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$39.89
Upside
+156.20%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Maintains $40 → $30 | Buy | Maintains | $40 → $30 | +92.68% | Aug 19, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $48 → $49 | Buy | Maintains | $48 → $49 | +214.71% | Aug 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $42 | Strong Buy | Initiates | $42 | +169.75% | Jun 30, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $48 | Buy | Reiterates | $48 | +208.29% | Jun 5, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $52 → $48 | Buy | Maintains | $52 → $48 | +208.29% | May 9, 2025 |
| Wedbush | Wedbush | Buy Maintains $43 | Buy | Maintains | $43 | +176.17% | Apr 21, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $56 → $52 | Buy | Maintains | $56 → $52 | +233.98% | Apr 3, 2025 |
| Scotiabank | Scotiabank | Buy → Hold Downgrades $50 → $14 | Buy → Hold | Downgrades | $50 → $14 | -10.08% | Apr 3, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $51 | Buy | Maintains | $51 | +227.55% | Apr 2, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $50 | Buy | Initiates | $50 | +221.13% | Mar 7, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $56 | Buy | Reiterates | $56 | +259.67% | Mar 4, 2025 |
| Stifel | Stifel | Hold Initiates $30 | Hold | Initiates | $30 | +92.68% | Jan 22, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $45 → $50 | Buy | Maintains | $45 → $50 | +221.13% | Dec 17, 2024 |
| Truist Securities | Truist Securities | Strong Buy Maintains $33 → $50 | Strong Buy | Maintains | $33 → $50 | +221.13% | Nov 27, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Initiates $45 | Buy | Initiates | $45 | +189.02% | Nov 22, 2024 |
| Wedbush | Wedbush | Buy Maintains $44 → $45 | Buy | Maintains | $44 → $45 | +189.02% | Nov 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.